A 31-year-old woman presented to the emergency department with progressive onset of left-side neck pain for 2 days. She had received the first dose of the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccine in her left arm 1 week before. On physical examination, she was afebrile with normal vitals. Neck examination was remarkable for multiple palpable, mobile, tender masses. Point-of-care ultrasound of the left side of the neck was performed (Figure , Video E1 [available at http://www.annemergmed.com]).
Diagnosis
Neck lymphadenitis after COVID-19 vaccination. Lymphadenitis resolved spontaneously 2 weeks later, and the patient was asymptomatic at the 1-month follow-up (Video E1 [available at http://www.annemergmed.com]). Systemic and local side effects commonly develop within 8 days of COVID-19 vaccination.1 Point-of-care ultrasound is an ideal noninvasive diagnostic tool for rapidly differentiating lymphadenitis from pathology.2 In ultrasonography, normal lymph nodes are 3 to 8 mm in size and are hypoechoic, elliptic, and elongated. Inflammation causes vasodilatation, which increases the vascularity as noted in the color Doppler mode.
Footnotes
For the diagnosis and teaching points, see page e14.
To view the entire collection of Images in Emergency Medicine, visitwww.annemergmed.com.
Supplementary Data
References
- 1.Menni C., Klaser K., May A., et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21:939–949. doi: 10.1016/S1473-3099(21)00224-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ahuja A.T., Ying M. Sonographic evaluation of cervical lymph nodes. AJR Am J Roentgenol. 2005;184:1691–1699. doi: 10.2214/ajr.184.5.01841691. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.